BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9590833)

  • 1. [Anterior chamber associated immune deviation inhibiting experimental autoimmune uveoretinitis].
    Zheng M; Ren P
    Zhonghua Yan Ke Za Zhi; 1996 Sep; 32(5):376-8. PubMed ID: 9590833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis.
    Konda BR; Pararajasegaram G; Wu GS; Stanforth D; Rao NA
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental autoimmune uveitis--a clinical and pathological study].
    Ren PX
    Zhonghua Yan Ke Za Zhi; 1992 Jan; 28(1):47-50. PubMed ID: 1499435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
    Butler TL; McMenamin PG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior chamber-associated immune deviation induced by soluble antigens.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive effect of anterior chamber associated immune deviation on endotoxin-induced uveitis].
    Fu T; Yang PZ; Huang XK; Zhou HY; Li FF; Huang Q
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1562-6. PubMed ID: 15500722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression and therapy of experimental autoimmune uveo-retinitis by injections of retinal extract (author's transl)].
    de Kozak Y; Faure JP; Ardy H; Usui M; Thillaye B
    Ann Immunol (Paris); 1978 Jan; 129(1):73-88. PubMed ID: 655648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous induction of immunoregulation by an endogenous retinal antigen.
    Gregerson DS; Dou C
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2984-91. PubMed ID: 12202519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.
    Dick AD; Cheng YF; Liversidge J; Forrester JV
    Immunology; 1994 Aug; 82(4):625-31. PubMed ID: 7835927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The propensity of different strains of guinea pigs to develop experimental autoimmune uveitis.
    McMaster PR; Wong VG; Owens JD
    Mod Probl Ophthalmol; 1976; 16():62-71. PubMed ID: 1250240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of mycobacterial hydrosoluble adjuvants on the induction and prevention of experimental autoimmune uveo-retinitis in guinea-pigs (author's transl)].
    de Kozak Y; Audibert F; Thillaye B; Chedid L; Faure JP
    Ann Immunol (Paris); 1979; 130C(1):29-32. PubMed ID: 434782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
    Jiang HR; Lumsden L; Forrester JV
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior chamber-associated immune deviation elicited via primate eyes.
    Eichhorn M; Horneber M; Streilein JW; Lutjen-Drecoll E
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2926-30. PubMed ID: 8360025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis.
    Verwaerde C; Naud MC; Delanoye A; Wood M; Thillaye-Goldenberg B; Auriault C; de Kozak Y
    Gene Ther; 2003 Nov; 10(23):1970-81. PubMed ID: 14528321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?
    Kreutzer B; Laliotou B; Cheng YF; Liversidge J; Forrester JV; Dick AD
    Eye (Lond); 1997; 11 ( Pt 4)():445-52. PubMed ID: 9425406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.